We are live on ! Find out more
GHDX

Genomic Health, Inc.
GHDX

Delisted

GHDX was delisted on the 7th of November, 2019.

Back to rankings

115 hedge funds and large institutions have $858M invested in Genomic Health, Inc. in 2013 Q2 according to their latest regulatory filings, with 115 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

55% less call options, than puts

Call options by funds: $2.69M | Put options by funds: $6M

Holders
115
Holders Change
+115
Holders Change %
–
% of All Funds
3.75%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
115
Increased
–
Reduced
–
Closed
–
Calls
$2.69M
Puts
$6M
Net Calls
-$3.31M
Net Calls Change
-$3.31M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
PPA
76
Parametric Portfolio Associates
Washington
$388K +$402K +12,233 New
Royal Bank of Canada
77
Royal Bank of Canada
Ontario, Canada
$366K +$380K +11,568 New
TAM
78
Tocqueville Asset Management
New York
$346K +$358K +10,900 New
BA
79
BlackRock Advisors
Delaware
$333K +$345K +10,512 New
PNC Financial Services Group
80
PNC Financial Services Group
Pennsylvania
$317K +$328K +10,000 New
VOYA Investment Management
81
VOYA Investment Management
Georgia
$312K +$323K +9,840 New
DT
82
Diversified Trust
Tennessee
$311K +$322K +9,800 New
NTCOC
83
Northern Trust Company of Connecticut
Connecticut
$288K +$298K +9,079 New
Principal Financial Group
84
Principal Financial Group
Iowa
$276K +$286K +8,697 New
SG Americas Securities
85
SG Americas Securities
New York
$275K +$285K +8,664 New
Citigroup
86
Citigroup
New York
$260K +$270K +8,225 New
UBS AM
87
UBS AM
Illinois
$257K +$266K +8,099 New
Barclays
88
Barclays
United Kingdom
$247K +$256K +7,796 New
D.E. Shaw & Co
89
D.E. Shaw & Co
New York
$238K +$246K +7,500 New
KCG
90
Knight Capital Group
$219K +$227K +6,907 New
US Bancorp
91
US Bancorp
Minnesota
$203K +$210K +6,402 New
Group One Trading
92
Group One Trading
Illinois
$202K +$209K +6,378 New
Public Employees Retirement Association of Colorado
93
Public Employees Retirement Association of Colorado
Colorado
$199K +$206K +6,282 New
Wells Fargo
94
Wells Fargo
California
$187K +$195K +5,923 New
QBFM
95
QS Batterymarch Financial Management
New York
$169K +$174K +5,300 New
TRCT
96
Tower Research Capital (TRC)
New York
$132K +$137K +4,173 New
MCM
97
Matarin Capital Management
New York
$75K +$78K +2,376 New
U
98
UBS
Switzerland
$44K +$46K +1,400 New
Ameriprise
99
Ameriprise
Minnesota
$37K +$38.5K +1,173 New
Teacher Retirement System of Texas
100
Teacher Retirement System of Texas
Texas
$33K +$34.4K +1,047 New
1 2 3
4
5

GHDX Hedge Fund Activity: Q2 2013 in Review

115 of the 3,065 institutional investors tracked by Wall St. Rank reported a position in Genomic Health, Inc. (GHDX) for Q2 2013, worth a combined $858M.

Buyers outnumbered sellers: 115 funds opened new GHDX positions and 0 closed out — a net gain of 115 holders — while 0 added to existing stakes and 0 trimmed.

  • 115 institutional investors held Genomic Health, Inc. (GHDX) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $858M of Genomic Health, Inc. stock for Q2 2013.
  • 115 funds opened new Genomic Health, Inc. positions in Q2 2013 and 0 closed out, a net change of +115 holders.

Based on aggregated 13F filings for Q2 2013.